SNBL’s nasal drug delivery platform is a proprietary system consisting of powder carrier technology and delivery device technology.





3D Nasal Cast Model
For Admin
SNBL, Ltd. and μco™ System are featured in the December 2012 edition of ONdrugDelivery Magazine. The article "A Nasal Delivery Solution to the Challenges in Biotherapeutic Delivery", highlights the capability of μco™ System to deliver biologics systemically via the nasal cavity. As examples, PK profiles of peptides (PTH 1-34 and Calcitonin) delivered by μco™ System in NHPs are shown.
Click here for PDF of the article.